Shopping Cart
- Remove All
- Your shopping cart is currently empty
VPC-14449 is a selective androgen receptor DNA-binding domain (AR-DBD) inhibitor, useful in prostate cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $392 | In Stock | |
5 mg | $952 | In Stock | |
10 mg | $1,290 | In Stock | |
25 mg | $1,920 | In Stock | |
50 mg | $2,500 | In Stock |
Description | VPC-14449 is a selective androgen receptor DNA-binding domain (AR-DBD) inhibitor, useful in prostate cancer research. |
Targets&IC50 | AR-DBD:0.34 μM |
In vitro | Methods: LNCaP, C4-2, MR49F, and 22Rv1 cells were treated with VPC-14449 (0.01-100 μM, 24 hours) to test its inhibitory effect on AR-V7 transcriptional activity in cells. Results: VPC-14449 inhibited AR transcriptional activity and cell viability in LNCaP, C4-2, MR49F, and 22Rv1 cells.[1] |
In vivo | Methods: Castrated mice were given VPC-14449 (100 mg/kg, ip, for 4 weeks) twice daily and LNCaP xenograft tumor volume and serum PSA were assessed. Results: VPC-14449 reduced tumor volume and abolished PSA production in the LNCaP xenograft model.[1] |
Alias | VPC14449 |
Molecular Weight | 394.09 |
Formula | C10H10Br2N4OS |
Cas No. | 1621375-32-3 |
Smiles | BrC=1N=C(Br)N(C1)C=2N=C(SC2)N3CCOCC3 |
Relative Density. | 2.12 g/cm3 (Predicted) |
Storage | keep away from direct sunlight,keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (253.75 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.